NCT04240535View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

May 31, 2020

Study Completion Date

July 31, 2020

Conditions

Aging

Interventions

DRUG

OnabotulinumtoxinA 50 UNT [Botox Cosmetic]

Injections to the Depressor Anguli Oris

Trial Locations (1)

92083

Moradi MD, Vista

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Amir Moradi MD, MBA

OTHER